Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) PYGO2 Antibodies:
anti-Rat (Rattus) PYGO2 Antibodies:
anti-Human PYGO2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal PYGO2 Primary Antibody for ChIP, ICC - ABIN4348740
Cantù, Valenta, Hausmann, Vilain, Aguet, Basler: The Pygo2-H3K4me2/3 interaction is dispensable for mouse development and Wnt signaling-dependent transcription. in Development (Cambridge, England) 2013
Show all 2 Pubmed References
Transcriptional cofactors Bcl9 (show BCL9 Antibodies), Bcl9l (show BCL9L Antibodies) and Pygo1 (show PYGO1 Antibodies)/2 act independently of beta-catenin (show CTNNB1 Antibodies) to ensure proper enamel formation.
It analyzed Wnt1 (show WNT1 Antibodies)-cre(+/-)::Pygo2(-/-) mice in which the beta-catenin (show CTNNB1 Antibodies) co-activator gene, Pygopus 2 (Pygo2), is deleted specifically in neural crest cells.
These findings identify Pygo2 as an important regulator of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) function in skin epithelia and p53 (show TP53 Antibodies) activation as a prominent downstream event of beta-catenin (show CTNNB1 Antibodies)/Pygo2 action in stem cell activation.
these results suggest that Pygo2 acts at a step downstream of mammary stem cell accumulation to facilitate transformation, and that it regulates the tumor initiating capacity and lineage preference of the already transformed mammary cells, in MMTV-Wnt1 (show WNT1 Antibodies) mice.
even in the absence of the potentially redundant Pygo1 (show PYGO1 Antibodies), Pygo2 does not require the H3K4me2/3 binding activity to sustain its function during mouse development
Mouse pygo2 expression was detected in the developing epidermis and hair follicles, which suggests that mpygo2 might mediate the effect of this signaling pathway in mouse skin.
In mammals, the Pygo1 (show PYGO1 Antibodies)/Pygo2 genes are not absolutely required for canonical Wnt (show WNT2 Antibodies) signaling in most developing systems, but rather function as quantitative transducers, or modulators, of Wnt (show WNT2 Antibodies) signal intensity
Pygo2 can function in the Wnt (show WNT2 Antibodies) pathway, but its activity in lens development is Wnt (show WNT2 Antibodies) pathway-independent
ablation of pygo2 expression causes defects in morphogenesis of both ectodermally and endodermally derived tissues, including brain, eyes, hair follicles, and lung
Study finds canonical Wnt (show WNT2 Antibodies) signaling to be predominantly active in the mesenchyme at the time when mPygo2 is required and demonstrate the dependence of Wnt (show WNT2 Antibodies) signal transduction on mPygo2.
We also determined the effect of Pygo2 on the sensitivity of breast tumors resistant to doxorubicin in a mouse model. Finally, RNA samples from 64 paired patient tumors (before and after chemotherapy) highly and significantly overexpressed Pygo2 and/or MDR1 after treatment, thus underlining a pivotal role for the Pygo2-mediated Wnt/b-catenin pathway in the clinical chemoresistance of breast cancer.
Findings are consistent with a model in which acetylation of Pygo2 by CBP/p300 (show CREBBP Antibodies) family members in the active TCF (show HNF4A Antibodies)/beta-catenin (show CTNNB1 Antibodies) complex occurs coincident with histone acetylation and may be required for the recycling of Pygo2 away from the complex subsequent to target gene activation.
The activation of its expression by ERalpha (show ESR1 Antibodies) and/or specificity protein-1 (SP1 (show SP1 Antibodies)) suggests hPYGO2 as a theranostic target for hormone therapy responsive and refractory breast cancer.
Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 (show MLL2 Antibodies) complex recruitment.
this study demonstrated that SNPs in the coding region of Pygo2 might be one of the causative factors in idiopathic oligospermia and azoospermia, resulting in male infertility.
Our findings suggest that Pygopus-2 may be an important predictor of poor outcome in HCC (show FAM126A Antibodies) patients, and could serve as a novel biomarker for HCC (show FAM126A Antibodies).
Pygopus-2 over-expression is associated with hepatic carcinoma.
Pygo2 is a common node downstream of oncogenic Wnt (show WNT2 Antibodies) and Akt (show AKT1 Antibodies) signaling pathways.
We conclude that abnormal Pygo2 protein expression may be a marker for advanced non-small cell lung cancer
PYGO2 is identified as a new molecular marker of invasive tumors in esophageal squamous cell carcinoma.
Involved in signal transduction through the Wnt pathway.
pygopus homolog 2
, pygopus 2